Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure
Crossref DOI link: https://doi.org/10.1038/s41598-020-75198-z
Published Online: 2020-10-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cheng, Tsung-Yi
Lee, Pei-Chang
Chen, Yi-Tzen
Chao, Yee
Hou, Ming-Chih
Huang, Yi-Hsiang
Text and Data Mining valid from 2020-10-27
Version of Record valid from 2020-10-27
Article History
Received: 2 May 2020
Accepted: 5 October 2020
First Online: 27 October 2020
Competing interests
: The authors declare no competing interests.